AJR Live Webinars feature leading experts discussing some of AJR’s most cutting-edge articles—broadcasted each month live, online, with CME.

Miss a broadcast? You can still watch past webinars and earn credit.

Past AJR Live Webinars

Upcoming Webinars

July 17, 2024

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Federica Vernuccio, MD, PhD
Speaker: Perry Pickhardt, MD

Metabolic dysfunction-associated steatotic liver disease, defined by the presence of liver steatosis together with at least one out of five cardiometabolic factors, is the most common cause of chronic liver disease worldwide. The diagnosis of steatosis, therefore, represents both a global public health threat and a precision medicine challenge. The results of this AJR study are important for the early detection of liver steatosis using both a quantitative biomarker routinely used on contrast-enhanced CT and an artificial intelligence (AI) tool that could allow for large-scale opportunistic evaluation.

In this webinar, AJR author Perry J. Pickhardt, MD, (2002 Figley Fellow) will outline a practical approach for using CT to assess hepatic steatosis, including hints for reporting in clinical practice. Participants will also learn how to use an automated AI tool to accurately diagnose at least moderate hepatic steatosis on portal venous phase postcontrast CT.

Register Now

Learning Outcomes

1. Outline a practical approach on the use of CT for the assessment of hepatic steatosis, with tips for clinical reporting.
2. Learn how to use automated artificial intelligence AI tool to accurately diagnose at least moderate hepatic steatosis on portal venous phase postcontrast CT.
3. Review findings for manually detecting at least moderate steatosis via quantitative biomarkers on portal venous phase postcontrast CT.
4. Discuss the accuracy and integration of manual and automated measurement of hepatic steatosis on portal venous phase postcontrast CT for opportunistic screening at a population level.

August 21, 2024

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Eric Y. Chang, MD
Speaker: O. Kenechi Nwawka, MD

Peripheral nerve imaging provides essential information for diagnosing, staging, and managing peripheral neuropathies. MRI and ultrasound are the imaging modalities of choice due to their high soft-tissue contrast and resolution, respectively. These techniques are critical for imaging in cases of trauma, entrapment syndromes, diffuse inflammatory neuropathies, and tumors.

In this comprehensive webinar, Drs. Kenny Nwawka and Eric Chang will explore both MRI and ultrasound-based techniques for peripheral nerve imaging discussed in this AJR article. Attendees will gain insights into the latest advancements in peripheral nerve imaging, facilitating early and accurate diagnoses for a variety of conditions. Additionally, an overview of image-guided nerve interventions will be presented, highlighting their role in the effective management of peripheral neuropathies.

Register Now

Disclosures

1. Eric Chang receives fees from JRF Ortho and has a relationship with GE Healthcare.
2. O. Kenechi Nwawka has nothing to disclose.

Learning Outcomes

1. Describe MRI- and ultrasound-based techniques for peripheral nerve imaging.
2. Discuss considerations for imaging in the settings of trauma, entrapment syndromes, diffuse inflammatory neuropathies, and tumors.
3. Appreciate the role of image-guided nerve interventions, including nerve blocks and ablations.

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

The ARRS designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.